CN Patent

CN106032356B — 一种[n-甲基-吡啶-2-基]氨基甲酸-1-氯乙酯的制备方法

Assigned to Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd · Expires 2018-09-14 · 8y expired

What this patent protects

本发明涉及一种[N‑甲基‑N‑3‑((叔丁氧基羰基甲基氨基)乙酰氧基甲基)吡啶‑2‑基]氨基甲酸‑1‑氯乙酯的制备方法。该方法是在低温下先将2‑(N‑甲基氨基)‑3‑羟甲基吡啶与Boc‑肌氨酸反应，然后再与氯甲酸‑1‑氯乙酯反应。本发明反应条件温和，产物后处理简单、纯度高，满足工业放大生产的基本要求。

USPTO Abstract

本发明涉及一种[N‑甲基‑N‑3‑((叔丁氧基羰基甲基氨基)乙酰氧基甲基)吡啶‑2‑基]氨基甲酸‑1‑氯乙酯的制备方法。该方法是在低温下先将2‑(N‑甲基氨基)‑3‑羟甲基吡啶与Boc‑肌氨酸反应，然后再与氯甲酸‑1‑氯乙酯反应。本发明反应条件温和，产物后处理简单、纯度高，满足工业放大生产的基本要求。

Drugs covered by this patent

Patent Metadata

Patent number
CN106032356B
Jurisdiction
CN
Classification
—
Expires
2018-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Chia Tai Fenghai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.